Tudor Investment Corp
ENFN

Tudor Investment Corp’s Enfusion, Inc. ENFN Stock Holding History

Tudor Investment Corp’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-25,256
Closed -$244K – 3044
2022
Q4 		$244K Buy
+25,256
New +$284K ﹤0.01% 2032
2022
Q3 		– Sell
-24,969
Closed -$255K – 2789
2022
Q2 		$255K Buy
24,969
+877
+4% +$9.69K 0.01% 1673
2022
Q1 		$306K Buy
24,092
+1,300
+6% +$19.9K 0.01% 1543
2021
Q4 		$477K Buy
+22,792
New +$461K 0.01% 1509

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
DIG
Dragoneer Investment Group San Francisco, California $3B AUM 6.95% 1-Year Est. Return
ACM
Ararat Capital Management Westport, Connecticut $178M AUM 26.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Tudor Investment Corp's ENFN Position: Q1 2023 in Review

Tudor Investment Corp sold out of Enfusion, Inc. (ENFN) in Q1 2023, closing a stake of 25,256 shares — an estimated $244K sold.

Tudor Investment Corp first reported a position in ENFN in Q4 2021 and held it in 4 quarters. The position peaked at $477K in Q4 2021. 90 funds tracked by Wall St. Rank hold ENFN as of Q1 2023.

  • Tudor Investment Corp reported no remaining Enfusion, Inc. position as of Q1 2023 after selling out during the quarter.
  • Tudor Investment Corp sold 25,256 Enfusion, Inc. shares in Q1 2023, an estimated $244K.
  • Tudor Investment Corp first reported a position in Enfusion, Inc. in Q4 2021 and held it in 4 quarters.
  • Tudor Investment Corp's Enfusion, Inc. position peaked at $477K in Q4 2021.
  • 90 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2023.

Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.